BioPharm Solutions, Inc. (BPS), a New Jersey-based, technology-orientated biopharmaceutical company, has developed a series of proprietary platform technologies for the delivery of biological therapeutics. These breakthrough technologies aim to overcome the long-standing technical obstacles to sustained-release delivery of structurally unaltered proteins, to non-invasive delivery of proteins and peptides, and to synthetic carriers of nucleotides.